Showing results (131-140 of 145) with videos related to
Sort By:
Pageof 15
Biochemical Pharmacology|September 12, 2012
Induction of caspase 8 and reactive oxygen species by ruthenium-derived anticancer compounds with improved water solubility and cytotoxicityVania Vidimar, Xiangjun Meng, Marcelina Klajner, et al.Nature Communications|March 13, 2021
Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implicationsNan Xiao, Meng Nie, Huanhuan Pang, et al.BMC Infectious Diseases|May 22, 2016
A novel multi-epitope recombined protein for diagnosis of human brucellosisDehui Yin, Li Li, Xiuling Song, et al.The Journal of Clinical Investigation|September 12, 2018
HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalkYingying Wang, Xiaoling Weng, Luoyang Wang, et al.Cancer Research|June 25, 2009
A ruthenium-containing organometallic compound reduces tumor growth through induction of the endoplasmic reticulum stress gene CHOPXiangjun Meng, Mili L Leyva, Marjorie Jenny, et al.JAMA Network Open|October 2, 2024
Eight-Week Supplementation With Bifidobacterium lactis HN019 and Functional Constipation: A Randomized Clinical TrialJing Cheng, Carl Gao, Reeta Ala-Jaakkola, et al.Journal of Hepatology|September 22, 2024
AI-Safe-C score: Assessing liver-related event risks in patients without cirrhosis after successful direct-acting antiviral treatmentHuapeng Lin, Terry Cheuk-Fung Yip, Hye Won Lee, et al.Communications Biology|November 14, 2022
Anti-tumor effects of P-LPK-CPT, a peptide-camptothecin conjugate, in colorectal cancerLidan Hou, Yichao Hou, Yu Liang, et al.EMBO Reports|February 16, 2023
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cellsYichao Hou, Xintian Zhang, Han Yao, et al.Oncogene|October 11, 2019
Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathwayYu Liang, Lidan Hou, Linjing Li, et al.Pageof 15